Discoidin domain receptor tyrosine kinases: New players in cancer progression

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 295-321

  Valiathan, Rajeshwari R ^a   Marco, Marta ^a   Leitinger, Birgit ^b   Kleer, Celina G ^c   Fridman, Rafael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell migration; Collagen; Discoidin domain receptor; Extracellular matrix; Metastasis; Signaling; Tyrosine kinase

Indexed keywords

BAFETINIB; COLLAGEN; DACTINOMYCIN; DASATINIB; DISCOIDIN DOMAIN RECEPTOR; ELVUCITABINE; ERLOTINIB; FOCAL ADHESION KINASE; H 126; IMATINIB; LCB 03 0110; LECTIN RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NILOTINIB; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; DICTYOSTELIUM DISCOIDEUM; EPSTEIN BARR VIRUS INFECTION; ESOPHAGUS CANCER; GENOMICS; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; IC 50; LEUKEMIA; LIVER CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; METASTASIS; MOLECULAR INTERACTION; MUTATION; NONHUMAN; PANCREAS CANCER; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SOLITARY FIBROUS TUMOR; SRC HOMOLOGY DOMAIN; THYROID CANCER;

ANIMALS; COLLAGEN; DISEASE PROGRESSION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SIGNAL TRANSDUCTION;

EID: 84862305477     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9346-z     Document Type: Review

References (187)

1. Johnson, J. D., Edman, J. C., & Rutter, W. J. (1993). A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proceedings of the National Academy of Sciences of the United States of America, 90(22), 10891.
2. Di Marco, E., Cutuli, N., Guerra, L., Cancedda, R., & De Luca, M. (1993). Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. The Journal of Biological Chemistry, 268(32), 24290-24295. (Pubitemid 23335418)
3. Zerlin, M., Julius, M. A., & Goldfarb, M. (1993). NEP: A novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene, 8(10), 2731-2739. (Pubitemid 23279101)
4. Karn, T., Holtrich, U., Brauninger, A., Bohme, B., Wolf, G., Rubsamen-Waigmann, H., et al. (1993). Structure, expression and chromosomal mapping of TKT from man and mouse: A new subclass of receptor tyrosine kinases with a factor VIII-like domain. Oncogene, 8(12), 3433-3440. (Pubitemid 23342644)
5. Perez, J. L., Shen, X., Finkernagel, S., Sciorra, L., Jenkins, N. A., Gilbert, D. J., et al. (1994). Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene, 9(1), 211-219. (Pubitemid 24020952)
6. Perez, J. L., Jing, S. Q., & Wong, T. W. (1996). Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene, 12(7), 1469-1477.
7. Lai, C., & Lemke, G. (1994). Structure and expression of the Tyro 10 receptor tyrosine kinase. Oncogene, 9(3), 877-883. (Pubitemid 24065927)
8. Laval, S., Butler, R., Shelling, A. N., Hanby, A. M., Poulsom, R., & Ganesan, T. S. (1994). Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth & Differentiation, 5(11), 1173-1183. (Pubitemid 24347396)
9. Sanchez, M. P., Tapley, P., Saini, S. S., He, B., Pulido, D., &Barbacid, M. (1994). Multiple tyrosine protein kinases in rat hippocampal neurons: Isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain. Proceedings of the National Academy of Sciences of the United States of America, 91(5), 1819-1823. (Pubitemid 24080297)
10. Alves, F., Vogel, W., Mossie, K., Millauer, B., Hofler, H., &Ullrich, A. (1995). Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene, 10(3), 609-618.
11. Vogel, W., Gish, G. D., Alves, F., & Pawson, T. (1997). The discoidin domain receptor tyrosine kinases are activated by collagen. Molecular Cell, 1(1), 13-23. (Pubitemid 127376389)
12. Shrivastava, A., Radziejewski, C., Campbell, E., Kovac, L., McGlynn, M., Ryan, T. E., et al. (1997). An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Molecular Cell, 1(1), 25-34. (Pubitemid 127376390)
13. Lemmon, M. A., & Schlessinger, J. (2010). Cell signaling by receptor tyrosine kinases. Cell, 141(7), 1117-1134. doi:10.1016/j.cell.2010.06.011.
14. Kiedzierska, A., Smietana, K., Czepczynska, H., & Otlewski, J. (2007). Structural similarities and functional diversity of eukaryotic discoidin-like domains. Biochimica et Biophysica Acta, 1774(9), 1069-1078. (Pubitemid 47333259)
15. Alexander, S., Sydow, L. M., Wessels, D., & Soll, D. R. (1992). Discoidin proteins of Dictyostelium are necessary for normal cytoskeletal organization and cellular morphology during aggregation. Differentiation, 51(3), 149-161.
16. Baumgartner, S., Hofmann, K., Chiquet-Ehrismann, R., &Bucher, P. (1998). The discoidin domain family revisited: New members from prokaryotes and a homology-based fold prediction. Protein Science, 7(7), 1626-1631. (Pubitemid 28331283)
17. Leitinger, B. (2011). Transmembrane collagen receptors. Annual Review of Cell and Developmental Biology, 27, 265-290. doi:10.1146/annurev-cellbio-092910- 154013.
18. Playford, M. P., Butler, R. J., Wang, X. C., Katso, R. M., Cooke, I. E., & Ganesan, T. S. (1996). The genomic structure of discoidin receptor tyrosine kinase. Genome Research, 6(7), 620-627. (Pubitemid 26275865)
19. Alves, F., Saupe, S., Ledwon, M., Schaub, F., Hiddemann, W., &Vogel, W. F. (2001). Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: Differential expression in human colon cancer cell lines. The FASEB Journal, 15(7), 1321-1323.
20. Curat, C. A., Eck, M., Dervillez, X., & Vogel, W. F. (2001). Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding. The Journal of Biological Chemistry, 276(49), 45952-45958.
21. Agarwal, G., Kovac, L., Radziejewski, C., & Samuelsson, S. J. (2002). Binding of discoidin domain receptor 2 to collagen I: An atomic force microscopy investigation. Biochemistry, 41(37), 11091-11098. (Pubitemid 35034010)
22. Agarwal, G., Mihai, C., & Iscru, D. F. (2007). Interaction of discoidin domain receptor 1 with collagen type 1. Journal of Molecular Biology, 367(2), 443-455. (Pubitemid 46295432)
23. Leitinger, B. (2003). Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. The Journal of Biological Chemistry, 278(19), 16761-16769.
24. Noordeen, N. A., Carafoli, F., Hohenester, E., Horton, M. A., &Leitinger, B. (2006). A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. The Journal of Biological Chemistry, 281(32), 22744-22751.
25. Mihai, C., Chotani, M., Elton, T. S., & Agarwal, G. (2009). Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. Journal of Molecular Biology, 385 (2), 432-445. doi:10.1016/j.jmb.2008.10.067.
26. Abdulhussein, R., Koo, D. H., & Vogel, W. F. (2008). Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1. The Journal of Biological Chemistry, 283(18), 12026-12033. doi:10.1074/jbc.M704592200.
27. Konitsiotis, A. D., Raynal, N., Bihan, D., Hohenester, E., Farndale, R. W., & Leitinger, B. (2008). Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. The Journal of Biological Chemistry, 283(11), 6861-6868.
28. Leitinger, B., Steplewski, A., & Fertala, A. (2004). The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2. Journal of Molecular Biology, 344(4), 993-1003. (Pubitemid 39491245)
29. Leitinger, B., & Kwan, A. P. (2006). The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biology, 25(6), 355-364. (Pubitemid 44175833)
30. Hou, G., Vogel, W., & Bendeck, M. P. (2001). The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. The Journal of Clinical Investigation, 107(6), 727-735. (Pubitemid 32225358)
31. Farndale, R. W., Lisman, T., Bihan, D., Hamaia, S., Smerling, C. S., Pugh, N., et al. (2008). Cell-collagen interactions: The use of peptide Toolkits to investigate collagen-receptor interactions. Biochemical Society Transactions, 36(Pt 2), 241-250. (Pubitemid 351570596)
32. Xu, H., Raynal, N., Stathopoulos, S., Myllyharju, J., Farndale, R. W., & Leitinger, B. (2011). Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biology, 30(1), 16-26. doi:10.1016/j.matbio.2010.10.004.
33. Abdulhussein, R., McFadden, C., Fuentes-Prior, P., & Vogel, W. F. (2004). Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor. The Journal of Biological Chemistry, 279(30), 31462-31470. (Pubitemid 39037814)
34. Ichikawa, O., Osawa, M., Nishida, N., Goshima, N., Nomura, N., & Shimada, I. (2007). Structural basis of the collagen-binding mode of discoidin domain receptor 2. EMBO Journal, 26(18), 4168-4176. (Pubitemid 47462092)
35. Carafoli, F., Bihan, D., Stathopoulos, S., Konitsiotis, A. D., Kvansakul, M., Farndale, R. W., et al. (2009). Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure, 17(12), 1573-1581. doi:10.1016/j.str.2009.10.012.
36. Lemeer, S., Bluwstein, A., Wu, Z., Leberfinger, J., Muller, K., Kramer, K., et al. (2011). Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. Journal of Proteomics. doi:10.1016/j.jprot.2011.10. 007.
37. L'Hote, C. G., Thomas, P. H., & Ganesan, T. S. (2002). Functional analysis of discoidin domain receptor 1: Effect of adhesion on DDR1 phosphorylation. The FASEB Journal, 16(2), 234-236.
38. Jonsson, M., & Andersson, T. (2001). Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. Journal of Cell Science, 114(Pt 11), 2043-2053. (Pubitemid 32586629)
39. Dejmek, J., Dib, K., Jonsson, M., & Andersson, T. (2003). Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. International Journal of Cancer, 103(3), 344-351. (Pubitemid 36076427)
40. Roarty, K., & Serra, R. (2007). Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development, 134(21), 3929-3939. (Pubitemid 350187351)
41. Lu, K. K., Trcka, D., & Bendeck, M. P. (2011). Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src. Cardiovascular Pathology, 20(2), 71-76. doi:10.1016/j.carpath.2009.12.006.
42. Ikeda, K., Wang, L. H., Torres, R., Zhao, H., Olaso, E., Eng, F. J., et al. (2002). Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. The Journal of Biological Chemistry, 277(21), 19206-19212. (Pubitemid 34952488)
43. Yang, K., Kim, J. H., Kim, H. J., Park, I. S., Kim, I. Y., & Yang, B. S. (2005). Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation. The Journal of Biological Chemistry, 280(47), 39058-39066. (Pubitemid 41713856)
44. Koo, D. H., McFadden, C., Huang, Y., Abdulhussein, R., Friese-Hamim, M., & Vogel,W. F. (2006). Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1. FEBS Letters, 580(1), 15-22. doi:10.1016/j.febslet.2005.11.035. (Pubitemid 43005305)
45. Wang, C. Z., Su, H. W., Hsu, Y. C., Shen, M. R., & Tang, M. J. (2006). A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Molecular Biology of the Cell, 17(6), 2839-2852.
46. Yang, G., Li, Q., Ren, S., Lu, X., Fang, L., Zhou, W., et al. (2009). Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins. Proteomics, 9(21), 4944-4961. doi:10.1002/pmic. 200800762.
47. Huang, Y., Arora, P., McCulloch, C. A., & Vogel, W. F. (2009). The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. Journal of Cell Science, 122(Pt 10), 1637-1646. doi:10.1242/jcs.046219.
48. Shintani, Y., Fukumoto, Y., Chaika, N., Svoboda, R., Wheelock, M. J., & Johnson, K. R. (2008). Collagen I-mediated upregulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. The Journal of Cell Biology, 180(6), 1277-1289. (Pubitemid 351468480)
49. Hansen, C., Greengard, P., Nairn, A. C., Andersson, T., & Vogel, W. F. (2006). Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Experimental Cell Research, 312(20), 4011-4018. doi:10.1016/j.yexcr.2006.09.003. (Pubitemid 44828046)
50. Hilton, H. N., Stanford, P. M., Harris, J., Oakes, S. R., Kaplan, W., Daly, R. J., et al. (2008). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta, 1783(3), 383-393.
51. Dejmek, J., Leandersson, K., Manjer, J., Bjartell, A., Emdin, S. O., Vogel, W. F., et al. (2005). Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clinical Cancer Research, 11(2 Pt 1), 520-528. (Pubitemid 40116875)
52. Kim, H. G., Hwang, S. Y., Aaronson, S. A., Mandinova, A., &Lee, S. W. (2011). DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. The Journal of Biological Chemistry, 286(20), 17672-17681. doi:10.1074/jbc.M111.236612.
53. Eswaramoorthy, R., Wang, C. K., Chen, W. C., Tang, M. J., Ho, M. L., Hwang, C. C., et al. (2010). DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation. Journal of Cellular Physiology, 224(2), 387-397. doi:10.1002/jcp.22134.
54. Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K., Leitinger, B., et al. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nature Cell Biology, 13(1), 49-58. doi:10.1038/ncb2133.
55. Olaso, E., Lin, H. C., Wang, L. H., & Friedman, S. L. (2011). Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrixremodeling. Fibrogenesis & Tissue Repair, 4(1), 5. doi:10.1186/1755-1536-4-5.
56. Wang, C. Z., Hsu, Y. M., & Tang, M. J. (2005). Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. Journal of Cellular Physiology, 203(1), 295-304.
57. Wang, C. Z., Yeh, Y. C., & Tang, M. J. (2009). DDR1/E-cadherin complex regulates the activation of DDR1 and cell spreading. American Journal of Physiology. Cell Physiology, 297(2), C419-C429. doi:10.1152/ajpcell.00101.2009.
58. Yeh, Y. C., Wang, C. Z., & Tang, M. J. (2009). Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. Journal of Cellular Physiology, 218(1), 146-156. doi:10.1002/jcp.21578.
59. Yeh, Y. C., Wu, C. C., Wang, Y. K., & Tang, M. J. (2011). DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Molecular Biology of the Cell, 22(7), 940-953. doi:10.1091/mbc.E10-08-0678.
60. Vonk, L. A., Doulabi, B. Z., Huang, C., Helder, M. N., Everts, V., & Bank, R. A. (2011). Collagen-induced expression of collagenase-3 by primary chondrocytes is mediated by integrin α1 and discoidin domain receptor 2: A protein kinase C-dependent pathway. Rheumatology, 50(3), 463-472. doi:10.1093/rheumatology/keq305.
61. Zhang, Y., Su, J., Yu, J., Bu, X., Ren, T., Liu, X., et al. (2011). An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. Journal of Bone and Mineral Research, 26 (3), 604-617. doi:10.1002/jbmr.225.
62. Lin, K. L., Chou, C. H., Hsieh, S. C., Hwa, S. Y., Lee, M. T., & Wang, F. F. (2010). Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. Journal of Bone and Mineral Research, 25(11), 2489-2503. doi:10.1002/jbmr.159.
63. Ongusaha, P. P., Kim, J. I., Fang, L., Wong, T. W., Yancopoulos, G. D., Aaronson, S. A., et al. (2003). p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO Journal, 22(6), 1289-1301. (Pubitemid 36362693)
64. Das, S., Ongusaha, P. P., Yang,Y. S., Park, J. M., Aaronson, S. A.,&Lee, S. W. (2006). Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Research, 66(16), 8123-8130. (Pubitemid 44299179)
65. Vogel, W., Brakebusch, C., Fassler, R., Alves, F., Ruggiero, F., &Pawson, T. (2000). Discoidin domain receptor 1 is activated independently of beta(1) integrin. The Journal of Biological Chemistry, 275(8), 5779-5784. (Pubitemid 30115222)
66. Suh, H. N., & Han, H. J. (2011). Collagen I regulates the self-renewal of mouse embryonic stem cells through alpha2beta1 integrin- and DDR1-dependent Bmi-1. Journal of Cellular Physiology. doi:10.1002/jcp.22697.
67. Chetoui, N., El Azreq, M. A., Boisvert, M., Bergeron, M. E., &Aoudjit, F. (2011). Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway. Journal of Cellular Biochemistry, 112(12), 3666-3674. doi:10.1002/jcb.23300.
68. Ruiz, P. A., & Jarai, G. (2011). Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. The Journal of Biological Chemistry, 286(15), 12912-12923. doi:10.1074/jbc.M110.143693.
69. Maeyama, M., Koga, H., Selvendiran, K., Yanagimoto, C., Hanada, S., Taniguchi, E., et al. (2008). Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition. Cancer, 113(10), 2823-2831. doi:10.1002/cncr.23900.
70. Camara, J., & Jarai, G. (2010). Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis & Tissue Repair, 3(1), 2. doi:10.1186/1755-1536-3-2.
71. Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15449-15454. doi:10.1073/pnas.1004900107.
72. Sakuma, S., Saya, H., Tada, M., Nakao, M., Fujiwara, T., Roth, J. A., et al. (1996). Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Letters, 398(2-3), 165-169. (Pubitemid 26414302)
73. Martinez-Marignac, V. L., Rodrigue, A., Davidson, D., Couillard, M., Al-Moustafa, A. E., Abramovitz, M., et al. (2011). The effect of a DNA repair gene on cellular invasiveness: XRCC3 overexpression in breast cancer cells. PloS One, 6(1), e16394. doi:10.1371/journal.pone.0016394.
74. Roig, B., Moyano, S., Martorell, L., Costas, J., & Vilella, E. (2011). The Discoidin domain receptor 1 gene has a functional A2RE sequence. Journal of Neurochemistry. doi:10.1111/j.1471-4159.2011.07580.x.
75. Shen, Q., Cicinnati, V. R., Zhang, X., Iacob, S., Weber, F., Sotiropoulos, G. C., et al. (2010). Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Molecular Cancer, 9, 227. doi:10.1186/1476-4598-9-227.
76. Chen, S. C., Wang, B. W., Wang, D. L., & Shyu, K. G. (2008). Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration. Biochemical and Biophysical Research Communications, 374(4), 662-667. doi:10.1016/j.bbrc.2008.07.092.
77. Shyu, K. G., Wang, B. W., & Chang, H. (2009). Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-alpha and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clinical Science, 116(7), 575-583. doi:10.1042/CS20080215.
78. Chua, H. H., Yeh, T. H., Wang, Y. P., Huang, Y. T., Sheen, T. S., Lo, Y. C., et al. (2008). Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma. Head & Neck, 30(4), 427-436.
79. Olaso, E., Ikeda, K., Eng, F. J., Xu, L.,Wang, L. H., Lin, H. C., et al. (2001). DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. The Journal of Clinical Investigation, 108(9), 1369-1378. (Pubitemid 33107765)
80. Sekiya, Y., Ogawa, T., Yoshizato, K., Ikeda, K., & Kawada, N. (2011). Suppression of hepatic stellate cell activation by microRNA-29b. Biochemical and Biophysical Research Communications, 412(1), 74-79. doi:10.1016/j.bbrc.2011. 07.041.
81. van Kilsdonk, J. W., van Kempen, L. C., van Muijen, G. N., Ruiter, D. J., & Swart, G. W. (2010). Soluble adhesion molecules in human cancers: Sources and fates. European Journal of Cell Biology, 89(6), 415-427. doi:10.1016/j.ejcb.2009.11.026.
82. Vogel, W. F. (2002). Ligand-induced shedding of discoidin domain receptor 1. FEBS Letters, 514(2-3), 175-180.
83. Slack, B. E., Siniaia, M. S., & Blusztajn, J. K. (2006). Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: Involvement of Src tyrosine kinase. Journal of Cellular Biochemistry, 98(3), 672-684. (Pubitemid 43727184)
84. Flynn, L. A., Blissett, A. R., Calomeni, E. P., & Agarwal, G. (2010). Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. Journal ofMolecular Biology, 395(3), 533-543. doi:10.1016/j.jmb.2009.10.073.
85. Lund, A. W., Stegemann, J. P., & Plopper, G. E. (2009). Mesenchymal stem cells sense three dimensional type I collagen through discoidin domain receptor 1. The Open Stem Cell Journal, 1, 40-53. doi:10.2174/ 1876893800901010040.
86. Torkamani, A., Verkhivker, G., & Schork, N. J. (2009). Cancer driver mutations in protein kinase genes. Cancer Letters, 281(2), 117-127. doi:10.1016/j.canlet.2008.11.008.
87. Hammerman, P. S., et al. (2011). Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery, 1(1), 78-89.
88. Ford, C. E., Lau, S. K., Zhu, C. Q., Andersson, T., Tsao, M. S., &Vogel, W. F. (2007). Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. British Journal of Cancer, 96(5), 808-814. (Pubitemid 46380188)
89. Yang, S. H., Baek, H. A., Lee, H. J., Park, H. S., Jang, K. Y., Kang, M. J., et al. (2010). Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncology Reports, 24(2), 311-319.
90. Valencia, K., Ormazabal, C., Zandueta, C., Luis-Ravelo, D., Anton, I., Pajares, M. J., et al. (2012). Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival. Homing and colonization in lung cancer bone metastasis. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-11-1686.
91. Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., et al. (2007). Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell, 131(6), 1190-1203. doi:10.1016/j.cell.2007.11.025. (Pubitemid 350235027)
92. Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., et al. (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Research, 65(17), 7591-7595. doi:10.1158/0008-5472.CAN-05- 1855. (Pubitemid 41297230)
93. Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., et al. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455(7216), 1069-1075. doi:10.1038/nature07423.
94. Vogel, W. F., Aszodi, A., Alves, F., & Pawson, T. (2001). Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Molecular and Cellular Biology, 21(8), 2906-2917. (Pubitemid 32244933)
95. Barker, K. T., Martindale, J. E., Mitchell, P. J., Kamalati, T., Page, M. J., Phippard, D. J., et al. (1995). Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours. Oncogene, 10(3), 569-575.
96. Neuhaus, B., Buhren, S., Bock, B., Alves, F., Vogel, W. F., &Kiefer, F. (2011). Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors. Cellular and Molecular Life Sciences: CMLS. doi:10.1007/s00018-011-0676-8.
97. Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciarkova, M., Ehrmann, J., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer, 7, 55. doi:10.1186/1471-2407-7-55.
98. Weiner, H. L., Rothman, M., Miller, D. C., & Ziff, E. B. (1996). Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatric Neurosurgery, 25 (2), 64-71. discussion 71-62.
99. Weiner, H. L., Huang, H., Zagzag, D., Boyce, H., Lichtenbaum, R., & Ziff, E. B. (2000). Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors. Neurosurgery, 47(6), 1400-1409.
100. Ram, R., Lorente, G., Nikolich, K., Urfer, R., Foehr, E., &Nagavarapu, U. (2006). Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. Journal of Neuro-Oncology, 76(3), 239-248.
101. Yamanaka, R., Arao, T., Yajima, N., Tsuchiya, N., Homma, J., Tanaka, R., et al. (2006). Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene, 25(44), 5994-6002. (Pubitemid 44477293)
102. Yoshida, D., & Teramoto, A. (2007). Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. Journal of Neuro-Oncology, 82(1), 29-40.
103. Heinzelmann-Schwarz, V. A., Gardiner-Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Davies, M. J., et al. (2004). Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clinical Cancer Research, 10(13), 4427-4436. (Pubitemid 38878885)
104. Quan, J., Yahata, T., Adachi, S., Yoshihara, K., & Tanaka, K. (2011). Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. International Journal of Molecular Sciences, 12 (2), 971-982. doi:10.3390/ijms12020971.
105. Colas, E., Perez, C., Cabrera, S., Pedrola, N., Monge, M., Castellvi, J., et al. (2011). Molecular markers of endometrial carcinoma detected in uterine aspirates. International Journal of Cancer. Journal International du Cancer, 129(10), 2435-2444. doi:10.1002/ijc.25901.
106. Nemoto, T., Ohashi, K., Akashi, T., Johnson, J. D., & Hirokawa, K. (1997). Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology, 65(4), 195-203. (Pubitemid 27472525)
107. Squire, J. A., Bayani, J., Luk, C., Unwin, L., Tokunaga, J., MacMillan, C., et al. (2002). Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head & Neck, 24(9), 874-887.
108. Gu, T. L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., et al. (2011). Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PloS One, 6(1), e15640. doi:10.1371/journal.pone. 0015640.
109. Couvelard, A., Hu, J., Steers, G., O'Toole, D., Sauvanet, A., Belghiti, J., et al. (2006). Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology, 131(5), 1597-1610. (Pubitemid 44780863)
110. Shimada, K., Nakamura, M., Ishida, E., Higuchi, T., Yamamoto, H., Tsujikawa, K., et al. (2008). Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Science, 99(1), 39-45. (Pubitemid 350239029)
111. Rodrigues, R., Roque, L., Espadinha, C., Pinto, A., Domingues, R., Dinis, J., et al. (2007). Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncology Reports, 18(4), 917-926.
112. Hajdu, M., Singer, S., Maki, R. G., Schwartz, G. K., Keohan, M. L., & Antonescu, C. R. (2010). IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. The Journal of Pathology, 221(3), 300-307. doi:10.1002/path.2715.
113. Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Wang, K. S., Mandelli, F., et al. (2005). Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clinical Cancer Research, 11(20), 7209-7219. doi:10.1158/1078-0432.CCR-04-2165. (Pubitemid 41507677)
114. Tomasson, M. H., Xiang, Z., Walgren, R., Zhao, Y., Kasai, Y., Miner, T., et al. (2008). Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood, 111(9), 4797-4808. doi:10.1182/blood-2007-09-113027.
115. Loriaux, M. M., Levine, R. L., Tyner, J. W., Frohling, S., Scholl, C., Stoffregen, E. P., et al. (2008). High-throughput sequenceanalysis of the tyrosine kinome in acute myeloid leukemia. Blood, 111(9), 4788-4796. doi:10.1182/blood-2007-07-101394.
116. Renne, C., Willenbrock, K., Kuppers, R., Hansmann, M. L., &Brauninger, A. (2005). Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood, 105 (10), 4051-4059. doi:10.1182/blood-2004-10-4008. (Pubitemid 40656155)
117. Willenbrock, K., Kuppers, R., Renne, C., Brune, V., Eckerle, S., Weidmann, E., et al. (2006). Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica, 91(5), 596-604. (Pubitemid 43799453)
118. Labrador, J. P., Azcoitia, V., Tuckermann, J., Lin, C., Olaso, E., Manes, S., et al. (2001). The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Reports, 2(5), 446-452. (Pubitemid 32519565)
119. Bargal, R., Cormier-Daire, V., Ben-Neriah, Z., Le Merrer, M., Sosna, J., Melki, J., et al. (2009). Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications. American Journal of Human Genetics, 84(1), 80-84. doi:10.1016/j.ajhg.2008.12.004.
120. Ali, B. R., Xu, H., Akawi, N. A., John, A., Karuvantevida, N. S., Langer, R., et al. (2010). Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Human Molecular Genetics, 19(11), 2239-2250. doi:10.1093/hmg/ddq103.
121. Kano, K., Marin de Evsikova, C., Young, J., Wnek, C., Maddatu, T. P., Nishina, P. M., et al. (2008). A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Molecular Endocrinology, 22(8), 1866-1880. doi:10.1210/me.2007-0310.
122. Matsumura, H., Kano, K., Marin de Evsikova, C., Young, J. A., Nishina, P. M., Naggert, J. K., et al. (2009). Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function. Physiological Genomics, 39(2), 120-129. doi:10.1152/ physiolgenomics.00073.2009.
123. Kano, K., Kitamura, A., Matsuwaki, T., Morimatsu, M., & Naito, K. (2010). Discoidin domain receptor 2 (DDR2) is required for maintenance of spermatogenesis in male mice. Molecular Reproduction and Development, 77(1), 29-37. doi:10.1002/mrd.21093.
124. Faraci-Orf, E., McFadden, C., & Vogel, W. F. (2006). DDR1 signaling is essential to sustain Stat5 function during lactogenesis. Journal of Cellular Biochemistry, 97(1), 109-121. doi:10.1002/jcb.20618. (Pubitemid 43050183)
125. Gross, O., Beirowski, B., Harvey, S. J., McFadden, C., Chen, D., Tam, S., et al. (2004). DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney International, 66(1), 102-111. (Pubitemid 38870086)
126. Curat, C. A., & Vogel, W. F. (2002). Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. Journal of the American Society of Nephrology, 13(11), 2648-2656. (Pubitemid 35216033)
127. Meyer zum Gottesberge, A. M., Gross, O., Becker-Lendzian, U., Massing, T., & Vogel, W. F. (2008). Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Laboratory Investigation, 88(1), 27-37.
128. Olaso, E., Labrador, J. P., Wang, L., Ikeda, K., Eng, F. J., Klein, R., et al. (2002). Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. The Journal of Biological Chemistry, 277 (5), 3606-3613. (Pubitemid 34953233)
129. Olaso, E., Arteta, B., Benedicto, A., Crende, O., & Friedman, S. L. (2011). Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liverassociated macrophages. The American Journal of Pathology, 179(6), 2894-2904. doi:10.1016/j.ajpath.2011.09.002.
130. Badiola, I., Olaso, E., Crende, O., Friedman, S. L., & Vidal-Vanaclocha, F. (2011). Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut. doi:10.1136/gutjnl-2011- 300810.
131. Roberts, M. E., Magowan, L., Hall, I. P., & Johnson, S. R. (2011). Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. The European Respiratory Journal, 37(6), 1482-1493. doi:10.1183/09031936.00039710.
132. Dang, N., Hu, J., Liu, X., Li, X., Ji, S., Zhang, W., et al. (2009). CD167 acts as a novel costimulatory receptor in T-cell activation. Journal of Immunotherapy, 32(8), 773-784. doi:10.1097/CJI.0b013e3181acea46.
133. Shyu, K. G., Wang, B. W., Kuan, P., & Chang, H. (2008). RNA interference for discoidin domain receptor 2 attenuates neointimal formation in balloon injured rat carotid artery. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(8), 1447-1453. doi:10.1161/ATVBAHA.108.165993.
134. Badiola, I., Villace, P., Basaldua, I., & Olaso, E. (2011). Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncology Reports, 26(4), 971-978. doi:10.3892/or.2011.1356.
135. Franco, C., Ahmad, P. J., Hou, G., Wong, E., & Bendeck, M. P. (2010). Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circulation Research, 106(11), 1775-1783. doi:10.1161/CIRCRESAHA.109.213637.
136. Wall, S. J., Werner, E., Werb, Z., & DeClerck, Y. A. (2005). Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. The Journal of Biological Chemistry, 280(48), 40187-40194. (Pubitemid 41779155)
137. Bhatt, R. S., Tomoda, T., Fang, Y., & Hatten, M. E. (2000). Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. Genes & Development, 14(17), 2216-2228.
138. Suzuki, N., Ando, S., Sumida, K., Horie, N., & Saito, K. (2011). Analysis of altered gene expression specific to embryotoxic chemical treatment during embryonic stem cell differentiation into myocardiac and neural cells. The Journal of Toxicological Sciences, 36(5), 569-585.
139. Franco-Pons, N., Tomas, J., Roig, B., Auladell, C., Martorell, L., & Vilella, E. (2009). Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro. Journal of Molecular Neuroscience: MN, 38(1), 2-11. doi:10.1007/s12031-008-9151-x.
140. Zurakowski, H., Gagnon, A., Landry, A., Layne, M. D., &Sorisky, A. (2007). Discoidin domain receptor 2 impairs insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation and glucose uptake in 3T3-L1 adipocytes. Hormone and Metabolic Research, 39(8), 575-581. (Pubitemid 47345232)
141. Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871-890. doi:10.1016/j.cell.2009.11.007.
142. Goldsmith, E. C., Zhang, X., Watson, J., Hastings, J., & Potts, J. D. (2010). The collagen receptor DDR2 is expressed during early cardiac development. Anatomical Record, 293(5), 762-769. doi:10.1002/ar.20922.
143. Zhou, B., von Gise, A., Ma, Q., Hu, Y. W., & Pu, W. T. (2010). Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Developmental Biology, 338(2), 251-261. doi:10.1016/j.ydbio.2009.12.007.
144. Walsh, L. A., Nawshad, A., & Medici, D. (2011). Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biology, 30(4), 243-247. doi:10.1016/j.matbio.2011.03.007.
145. Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., et al. (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene, 24(14), 2375-2385. doi:10.1038/sj.onc.1208429. (Pubitemid 40546696)
146. Blick, T., Hugo, H.,Widodo, E.,Waltham, M., Pinto, C., Mani, S. A., et al. (2010). Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. Journal of Mammary Gland Biology and Neoplasia, 15(2), 235-252. doi:10.1007/s10911-010-9175-z.
147. Hou, G., Vogel, W. F., & Bendeck, M. P. (2002). Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circulation Research, 90(11), 1147-1149. (Pubitemid 34786897)
148. Kamohara, H., Yamashiro, S., Galligan, C., & Yoshimura, T. (2001). Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. The FASEB Journal, 15(14), 2724-2726.
149. Fukunaga-Kalabis, M., Martinez, G., Liu, Z. J., Kalabis, J., Mrass, P., Weninger, W., et al. (2006). CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. The Journal of Cell Biology, 175(4), 563-569. (Pubitemid 44790610)
150. Franco, C., Britto, K., Wong, E., Hou, G., Zhu, S. N., Chen, M., et al. (2009). Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circulation Research, 105(11), 1141-1148. doi:10.1161/CIRCRESAHA.109.207357.
151. Song, S., Shackel, N. A., Wang, X. M., Ajami, K., McCaughan, G. W., & Gorrell, M. D. (2011). Discoidin domain receptor 1: Isoform expression and potential functions in cirrhotic human liver. The American Journal of Pathology, 178(3), 1134-1144. doi:10.1016/j.ajpath.2010.11.068.
152. Hou, G.,Wang, D., & Bendeck, M. P. (2011). Deletion of discoidin domain receptor 2 does not affect smooth muscle cell adhesion, migration, or proliferation in response to type I collagen. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology. doi:10.1016/j.carpath.2011.07.006.
153. Bhadriraju, K., Chung, K. H., Spurlin, T. A., Haynes, R. J., Elliott, J. T., & Plant, A. L. (2009). The relative roles of collagen adhesive receptor DDR2 activation and matrix stiffness on the downregulation of focal adhesion kinase in vascular smooth muscle cells. Biomaterials, 30(35), 6687-6694. doi:10.1016/j.biomaterials.2009.08.036.
154. Zamir, E., & Geiger, B. (2001). Components of cell-matrix adhesions. Journal of Cell Science, 114(Pt 20), 3577-3579. (Pubitemid 33041039)
155. Etienne, J., & Duperray, A. (2011). Initial dynamics of cell spreading are governed by dissipation in the actin cortex. Biophysical Journal, 101(3), 611-621. doi:10.1016/j.bpj.2011.06.030.
156. Hachehouche, L. N., Chetoui, N., & Aoudjit, F. (2010). Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen. Molecular Immunology, 47(9), 1866-1869. doi:10.1016/j.molimm.2010.02.023.
157. Guerrot, D., Kerroch, M., Placier, S., Vandermeersch, S., Trivin, C., Mael-Ainin, M., et al. (2011). Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. The American Journal of Pathology, 179(1), 83-91. doi:10.1016/j.ajpath.2011.03.023.
158. Park, H. S., Kim, K. R., Lee, H. J., Choi, H. N., Kim, D. K., Kim, B. T., et al. (2007). Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncology Reports, 18(6), 1435-1441.
159. Castro-Sanchez, L., Soto-Guzman, A., Navarro-Tito, N., Martinez-Orozco, R., & Salazar, E. P. (2010). Native type IV collagen induces cell migration through a CD9 and DDR1- dependent pathway in MDA-MB-231 breast cancer cells. European Journal of Cell Biology, 89(11), 843-852. doi:10.1016/j.ejcb.2010.07. 004.
160. Rowe, R. G., & Weiss, S. J. (2009). Navigating ECM barriers at the invasive front: The cancer cell-stroma interface. Annual Review of Cell and Developmental Biology, 25, 567-595. doi:10.1146/annurev.cellbio.24.110707. 175315.
161. Castro-Sanchez, L., Soto-Guzman, A., Guaderrama-Diaz, M., Cortes-Reynosa, P., & Salazar, E. P. (2011). Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells. Clinical & Experimental Metastasis, 28(5), 463-477. doi:10.1007/s10585-011-9385-9.
162. Gschwind, A., Fischer, O. M., & Ullrich, A. (2004). The discovery of receptor tyrosine kinases: Targets for cancer therapy. Nature Reviews. Cancer, 4(5), 361-370. doi:10.1038/nrc1360. (Pubitemid 38579482)
163. Zhang, J., Yang, P. L., & Gray, N. S. (2009). Targeting cancer with small molecule kinase inhibitors. Nature Reviews. Cancer, 9 (1), 28-39. doi:10.1038/nrc2559.
164. Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., et al. (2007). Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood, 110 (12), 4055-4063. doi:10.1182/blood-2007-07-102061. (Pubitemid 350248462)
165. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., et al. (2007). Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nature Biotechnology, 25(9), 1035-1044. doi:10.1038/nbt1328. (Pubitemid 47517638)
166. Hantschel, O., Rix, U., & Superti-Furga, G. (2008). Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leukemia & Lymphoma, 49(4), 615-619. doi:10.1080/10428190801896103. (Pubitemid 351517198)
167. Day, E., Waters, B., Spiegel, K., Alnadaf, T., Manley, P. W., Buchdunger, E., et al. (2008). Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. European Journal of Pharmacology, 599(1-3), 44-53. doi:10.1016/j.ejphar.2008.10.014.
168. Li, J., Rix, U., Fang, B., Bai, Y., Edwards, A., Colinge, J., et al. (2010). A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nature Chemical Biology, 6(4), 291-299. doi:10.1038/nchembio.332.
169. Rix, U., Remsing Rix, L. L., Terker, A. S., Fernbach, N. V., Hantschel, O., Planyavsky, M., et al. (2010). A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. Leukemia, U.K, 24(1), 44-50. doi:10.1038/leu.2009.228.
170. Sun, X., Phan, T. N., Jung, S. H., Kim, S. Y., Cho, J. U., Lee, H., et al. (2011). LCB 03-0110, a novel pan-DDR/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation. The Journal of Pharmacology and Experimental Therapeutics. doi:10.1124/jpet.111. 187328.
171. Yang, X., Huang, Y., Crowson, M., Li, J., Maitland, M. L., &Lussier, Y. A. (2010). Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data. Journal of Biomedical Informatics, 43(3), 376-384. doi:10.1016/j.jbi.2010.04.006.
172. Du, J., Bernasconi, P., Clauser, K. R., Mani, D. R., Finn, S. P., Beroukhim, R., et al. (2009). Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology, 27(1), 77-83. doi:10.1038/nbt.1513.
173. Mihai, C., Iscru, D. F., Druhan, L. J., Elton, T. S., & Agarwal, G. (2006). Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1. Journal of Molecular Biology, 361(5), 864-876.
174. Siddiqui, K., Kim, G. W., Lee, D. H., Shin, H. R., Yang, E. G., Lee, N. T., et al. (2009). Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library. Biological & Pharmaceutical Bulletin, 32(1), 136-141.
175. Turashvili, G., Bouchal, J., Ehrmann, J., Fridman, E., Skarda, J., & Kolar, Z. (2007). Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 151(1), 59-64.
176. Tun, H. W., Personett, D., Baskerville, K. A., Menke, D. M., Jaeckle, K. A., Kreinest, P., et al. (2008). Pathway analysis of primary central nervous system lymphoma. Blood, 111(6), 3200-3210. doi:10.1182/blood-2007-10-119099.
177. Ahmad, P. J., Trcka, D., Xue, S., Franco, C., Speer, M. Y., Giachelli, C. M., et al. (2009). Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. The American Journal of Pathology, 175(6), 2686-2696. doi:10.2353/ajpath.2009. 080734.
178. Flamant, M., Placier, S., Rodenas, A., Curat, C. A., Vogel, W. F., Chatziantoniou, C., et al. (2006). Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. Journal of the American Society of Nephrology, 17(12), 3374-3381. (Pubitemid 44865280)
179. Avivi-Green, C., Singal, M., & Vogel, W. F. (2006). Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine, 174(4), 420-427. (Pubitemid 44223123)
180. Franco, C., Hou, G., Ahmad, P. J., Fu, E. Y., Koh, L., Vogel, W. F., et al. (2008). Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circulation Research, 102(10), 1202-1211. doi:10.1161/CIRCRESAHA.107.170662.
181. Gross, O., Girgert, R., Beirowski, B., Kretzler, M., Kang, H. G., Kruegel, J., et al. (2010). Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biology, 29(5), 346-356. doi:10.1016/j.matbio.2010.03.002.
182. Ferri, N., Carragher, N. O., & Raines, E. W. (2004). Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: Potential implications in atherosclerosis and lymphangioleiomyomatosis. American Journal of Pathology, 164(5), 1575-1585. (Pubitemid 38529760)
183. Blissett, A. R., Garbellini, D., Calomeni, E. P., Mihai, C., Elton, T. S., & Agarwal, G. (2009). Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2. Journal of Molecular Biology, 385(3), 902-911. doi:10.1016/j.jmb.2008.10.060.
184. Xu, L., Peng,H.,Wu,D.,Hu,K.,Goldring,M. B.,Olsen, B. R., et al. (2005). Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. The Journal of Biological Chemistry, 280(1), 548-555. (Pubitemid 40165020)
185. Xu, L., Peng, H., Glasson, S., Lee, P. L., Hu, K., Ijiri, K., et al. (2007). Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis and Rheumatism, 56(8), 2663-2673. (Pubitemid 47237284)
186. Wang, J., Lu, H., Liu, X., Deng, Y., Sun, T., Li, F., et al. (2002). Functional analysis of discoidin domain receptor 2 in synovial fibroblasts in rheumatoid arthritis. Journal of Autoimmunity, 19 (3), 161-168. (Pubitemid 35341866)
187. Su, J., Yu, J., Ren, T., Zhang,W., Zhang, Y., Liu, X., et al. (2009). Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis. Molecular and Cellular Biochemistry, 330(1-2), 141-152. doi:10.1007/s11010-009- 0127-0.